QDEL News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

QD

Mkt Cap

$885.1M

Volume

1.28M

Next Earnings

November 4th

Loading chart

QD

QDELQuidelOrtho Corporation Common Stock

QDEL

Pay with—

Available Balance0.00

QD

Mkt Cap

$953.9M

Volume

1.28M

Next Earnings

November 4th

Chart Financials Earnings News About Insider Filings

Reasons to Add QuidelOrtho Stock to Your Portfolio for NowQuidelOrtho Corporation (QDEL) shows strong Q2 2026 results with 21% adjusted EBITDA growth and expanding margins, supported by a diversified product portfolio and $50 million cost-saving initiatives through 2027. However, weak respiratory demand and overdependence on this segment pose risks, with the company adopting a cautious outlook for the 2026-2027 respiratory season.Zacks Investment Research · Oct 14, 2026

Lateral Flow Assay Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035The global lateral flow assay market is projected to grow from USD 10.84 billion in 2025 to USD 17.66 billion by 2035, with a 5.0% CAGR. Growth is driven by increased adoption of point-of-care testing, technological innovations including CRISPR-based assays, and the shift toward decentralized diagnostic models. Major players include Abbott, Roche, Siemens Healthineers, and Thermo Fisher Scientific, with infectious disease testing accounting for 72.2% of market share.GlobeNewswire Inc. · Aug 31, 2026

Pregnancy Detection Kits Market Analysis Report 2026 - Competitive Landscape, Opportunities, and Forecasts, 2021-2025 & 2025-2031The global pregnancy detection kits market is projected to grow from USD 1.91 billion in 2025 to USD 2.69 billion by 2031, with a CAGR of 5.87%. Growth is driven by technological advancements enabling earlier detection, rising infertility rates, and increasing adoption of digital integration and e-commerce distribution. However, the market faces challenges from accuracy concerns and user error risks that erode consumer trust.GlobeNewswire Inc. · May 8, 2026

Rice Hall James Buys QuidelOrtho StockRice Hall James & Associates purchased 574,877 shares of QuidelOrtho in Q4, increasing its stake to 833,791 shares valued at $23.8 million (1.3% of fund assets). The investment reflects confidence in the diagnostic technology company despite its stock being down 43.4% over the past year, as value investors anticipate improved financial results from recent leadership changes and strategic adjustments.The Motley Fool · Mar 9, 2026

QuidelOrtho Corp Director Purchases 10k Shares as CFO RetiresQuidelOrtho board director Matthew Strobeck purchased 10,000 shares for ~$240,000 on Feb. 13, 2026, as the company faces another executive transition with CFO Joseph Busky's retirement effective in June. The diagnostics company continues struggling with its third consecutive year of declining revenue and net losses, with stock down ~44% over the past year.The Motley Fool · Mar 2, 2026

QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmLaw firm investigating potential claims against QuidelOrtho for allegedly misleading investors about COVID-19 test revenues and product launch during 2022-2024, with significant earnings miss and revenue forecast reduction in February 2024.GlobeNewswire Inc. · Sep 4, 2025

Lateral Flow Assays Market to Grow at a CAGR of 7.5% During the Forecast Period (2025 – 2030): Wissen ResearchThe global lateral flow assay market is projected to grow from $8.2 billion in 2024 to $12.6 billion by 2030, with a 7.5% CAGR. North America is expected to lead market growth, driven by advanced healthcare infrastructure and rapid diagnostic innovations.GlobeNewswire Inc. · Aug 28, 2025

QuidelOrtho (QDEL) Fiscal Q2 EPS BeatsQuidelOrtho reported Q2 FY2025 financial results with narrowly surpassed revenue estimates, improved adjusted EPS, and significant restructuring charges, reflecting ongoing market contraction and strategic shifts in diagnostic testing solutions.The Motley Fool · Aug 6, 2025

Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and TreatmentThe global molecular diagnostics for infectious disease market is poised for growth, driven by advancements in biotechnology and genomics, as well as the impact of multiplex assays on diagnosis and treatment. The report covers dynamic trends, including pathogen evolution, globalization, and climate change impacts, and provides insights on the U.S. Medicare Fee Schedules and global data.GlobeNewswire Inc. · Jun 6, 2025

Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsightThe metastatic colorectal cancer clinical trial pipeline is accelerating, with over 150 pharmaceutical companies rigorously developing drugs for market entry. This indicates a positive sentiment for the industry as it aims to address the rising incidence of the disease.GlobeNewswire Inc. · May 14, 2025

to start trading

QD

QDELQuidelOrtho Corporation Common Stock

QDEL

Pay with—

Available Balance0.00

Your PositionYou don't own any QDEL yet.

Related Tickers

Earnings